Growth Metrics

Cellectis (CLLS) Accumulated Depreciation & Amortization: 2015-2022

  • Cellectis' Accumulated Depreciation & Amortization rose 21.07% to $32.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $197.9 million, marking a year-over-year decrease of 23.37%. This contributed to the annual value of $10.7 million for FY2024, which is 6.74% up from last year.
  • Cellectis' Accumulated Depreciation & Amortization amounted to $32.8 million in Q4 2022, which was up 21.07% from $27.1 million recorded in Q4 2021.
  • Cellectis' 5-year Accumulated Depreciation & Amortization high stood at $116.6 million for Q2 2021, and its period low was $17.4 million during Q4 2018.
  • For the 3-year period, Cellectis' Accumulated Depreciation & Amortization averaged around $58.2 million, with its median value being $32.8 million (2022).
  • Data for Cellectis' Accumulated Depreciation & Amortization shows a peak YoY skyrocketed of 174.81% (in 2020) over the last 5 years.
  • Over the past 5 years, Cellectis' Accumulated Depreciation & Amortization (Quarterly) stood at $17.4 million in 2018, then climbed by 2.23% to $17.8 million in 2019, then rose by 19.94% to $21.4 million in 2020, then rose by 26.90% to $27.1 million in 2021, then increased by 21.07% to $32.8 million in 2022.
  • Its Accumulated Depreciation & Amortization stands at $32.8 million for Q4 2022, versus $27.1 million for Q4 2021 and $116.6 million for Q2 2021.